University Hospitals’ cardiologists advocate for superior treatment with drug-coated balloons in JACC article

Tuesday, March 06, 2018
CLEVELAND – Facts are stubborn but the desire to ignore them in the face of evidence should be inexcusable.

University Hospitals Cleveland Medical Center (UHCMC) cardiology interventionalists authored a new article in the Journal of the American College of Cardiology (JACC) entitled, “Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons,” (embargoed until March 5, 2 p.m.) that is critical of the Center of Medicare and Medicaid (CMS) recent decision to not pay for drug-coated balloons despite their clinical superiority.
The CMS decided to end transitional pass through (TPT) add-on payment for drug-coated balloons at the first of the year without creating a new payment classification for the devices.
The outpatient hospital TPT add-on payment program is specifically designed to support patient access to new technologies that meet stringent criteria pertaining to clinical effectiveness.

Download full release

<< Back

You must be logged in to view this item.


This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.